ALIAD

Established in 2013, ALIAD is the corporate venture capital arm of Air Liquide, focusing on minority investments in innovative startups that align with the company's strategic objectives. The firm primarily targets sectors such as energy transition, healthcare, and digital technologies, leveraging Air Liquide's industrial and technological expertise to support the growth of these startups.

ALIAD's investment strategy encompasses various stages, including Pre-Seed, Seed, Early Stage, Series A, Series B, Growth, Late Stage, and Pre-IPO, with typical investments ranging from €100,000 to €1.5 million. The firm has a global geographical focus, with investments in countries such as France, the United States, Germany, the United Kingdom, China, Japan, India, South Korea, Italy, Spain, the Netherlands, Belgium, Switzerland, Canada, Australia, Brazil, Mexico, South Africa, Russia, and Saudi Arabia.

Since its inception, ALIAD has invested in over 40 startups and 7 funds, contributing to the development of technologies in energy transition, healthcare, and digital sectors. The firm's involvement often includes technological and business agreements between the startups and Air Liquide's entities, fostering mutually beneficial partnerships that generate value for both parties.